Two patterns of thrombopoietin signaling suggest no coupling between platelet production and thrombopoietin reactivity in thrombocytopenia-absent radii syndrome

Background Thrombocytopenia with absent radii syndrome is defined by bilateral radius aplasia and thrombocytopenia. Due to impaired thrombopoietin signaling there are only few bone marrow megakaryocytes and these are immature; the resulting platelet production defect improves somewhat over time. A microdeletion on chromosome 1q21 is present in all patients but is not sufficient to form thrombocytopenia with absent radii syndrome. We aimed to refine the signaling defect in this syndrome. Design and Methods We report an extended study of 23 pediatric and adult patients suffering from thrombocytopenia with absent radii syndrome in order to scrutinize thrombopoietin signal transduction by immunoblotting and gel electrophoretic shift assays. In addition, platelet immunotyping and reactivity were analyzed by flow cytometry. Results were correlated with clinical data including age and platelet counts. Results Two distinct signaling patterns were identified. Juvenile patients showed abrogated thrombopoietin signaling (pattern #1), which is restored in adults (pattern #2). Phosphorylated Jak2 was indicative of activation of STAT1, 3 and 5, Tyk2, ERK, and Akt, showing its pivotal role in distinct thrombopoietin-dependent pathways. Jak2 cDNA was not mutated and the thrombopoietin receptor was present on platelets. All platelets of patients expressed normal levels of CD41/61, CD49b, and CD49f receptors, while CD42a/b and CD29 were slightly reduced and the fibronectin receptor CD49e markedly reduced. Lysosomal granule release in response to thrombin receptor activating peptide was diminished. Conclusions We show a combined defect of platelet production and function in thrombocytopenia with absent radii syndrome. The rise in platelets that most patients have during the first years of life preceded the restored thrombopoietin signaling detected at a much later age, implying that these events are uncoupled and that an unknown factor mediates the improvement of platelet production.

[1]  L. Rimsza,et al.  Developmental differences in megakaryocytopoiesis are associated with up-regulated TPO signaling through mTOR and elevated GATA-1 levels in neonatal megakaryocytes. , 2011, Blood.

[2]  P. Noris,et al.  Eltrombopag for the treatment of the inherited thrombocytopenia deriving from MYH9 mutations. , 2010, Blood.

[3]  R. Gutti,et al.  Neonatal thrombocytopenia and megakaryocytopoiesis. , 2010, Seminars in hematology.

[4]  Je-Yong Choi,et al.  Thioredoxin-Interacting Protein Regulates Hematopoietic Stem Cell Quiescence and Mobilization under Stress Conditions1 , 2009, The Journal of Immunology.

[5]  A. Geddis.  Congenital amegakaryocytic thrombocytopenia and thrombocytopenia with absent radii. , 2009, Hematology/oncology clinics of North America.

[6]  F. Alviano,et al.  Thrombocytopenia with absent radii (TAR) syndrome: from hemopoietic progenitor to mesenchymal stromal cell disease? , 2009, Experimental hematology.

[7]  Y. Sekine,et al.  An RNA biding protein, Y14 interacts with and modulates STAT3 activation. , 2008, Biochemical and biophysical research communications.

[8]  Bin Zhou,et al.  TPO-independent megakaryocytopoiesis. , 2008, Critical reviews in oncology/hematology.

[9]  F. Lanza,et al.  Recombinant activated factor VII for hemostatic cover of orthopedic interventions in a girl with thrombocytopenia with absent radii syndrome. , 2007, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[10]  Reinhard Ullmann,et al.  Complex inheritance pattern resembling autosomal recessive inheritance involving a microdeletion in thrombocytopenia-absent radius syndrome. , 2007, American journal of human genetics.

[11]  L. Rimsza,et al.  Differential effects of recombinant thrombopoietin and bone marrow stromal-conditioned media on neonatal versus adult megakaryocytes. , 2006, Blood.

[12]  D. Gilliland,et al.  The JAK2V617F tyrosine kinase mutation in myeloproliferative disorders: Summary of published literature and a perspective , 2006, Current hematologic malignancy reports.

[13]  M. Teufel,et al.  Consanguinity in a Turkish family with thrombocytopenia with absent radii (TAR) syndrome , 1983, Human Genetics.

[14]  F. Niethard,et al.  Thrombocytopenia and absent radius (TAR) syndrome , 2004, International Orthopaedics.

[15]  R. Go,et al.  Acute myelogenous leukemia in an adult with thrombocytopenia with absent radii syndrome , 2003, European journal of haematology.

[16]  H. Brunner,et al.  Thrombocytopenia-absent radius syndrome: a clinical genetic study , 2002, Journal of medical genetics.

[17]  B. Alter.  Bone marrow failure syndromes in children. , 2002, Pediatric clinics of North America.

[18]  M. Ratajczak,et al.  Thrombopoietin, but not cytokines binding to gp130 protein-coupled receptors, activates MAPKp42/44, AKT, and STAT proteins in normal human CD34+ cells, megakaryocytes, and platelets. , 2002, Experimental hematology.

[19]  M. Kondo,et al.  Conserved physical linkage of GnRH-R and RBM8 in the medaka and human genomes. , 2002, Biochemical and biophysical research communications.

[20]  W. Vainchenker,et al.  Absence of mutations in the HoxA10, HoxA11 and HoxD11 nucleotide coding sequences in thrombocytopenia with absent radius syndrome , 2002, British Journal of Haematology.

[21]  Z. Fadoo,et al.  Acute myeloid leukemia in a patient with thrombocytopenia with absent radii syndrome. , 2002, Journal of pediatric hematology/oncology.

[22]  C. Dempfle,et al.  Increase in platelet count in response to rHuEpo in a patient with thrombocytopenia and absent radii syndrome. , 2001, Blood.

[23]  R. Christensen,et al.  Dose–response relationship of megakaryocyte progenitors from the bone marrow of thrombocytopenic and non‐thrombocytopenic neonates to recombinant thrombopoietin , 2000, British journal of haematology.

[24]  W. Vainchenker,et al.  Existence of a differentiation blockage at the stage of a megakaryocyte precursor in the thrombocytopenia and absent radii (TAR) syndrome. , 2000, Blood.

[25]  M. Ballmaier,et al.  Thrombopoietin induces the generation of distinct Stat1, Stat3, Stat5a and Stat5b homo- and heterodimeric complexes with different kinetics in human platelets. , 2000, Experimental hematology.

[26]  K. Kaushansky,et al.  Thrombopoietin Signal Transduction Requires Functional JAK2, Not TYK2* , 1999, The Journal of Biological Chemistry.

[27]  R. Crownover.  Hematology/Oncology Clinics of North America: Preface , 1999 .

[28]  A. Savoia,et al.  Mutational screening of thrombopoietin receptor gene (c‐mpl) in patients with congenital thrombocytopenia and absent radii (TAR) , 1998, British journal of haematology.

[29]  L. Vaickus,et al.  Recombinant Interleukin‐6 in the Treatment of Congenital Thrombocytopenia Associated With Absent Radii , 1998, Journal of pediatric hematology/oncology.

[30]  M. Ballmaier,et al.  Defective c‐Mpl signaling in the syndrome of thrombocytopenia with absent radii , 1998, Stem cells.

[31]  S. Goff,et al.  The Thrombopoietin Receptor Can Mediate Proliferation without Activation of the Jak-STAT Pathway , 1997, The Journal of experimental medicine.

[32]  P Jay,et al.  Specific inhibition of Stat3 signal transduction by PIAS3. , 1997, Science.

[33]  M. Ballmaier,et al.  Thrombopoietin in patients with congenital thrombocytopenia and absent radii: elevated serum levels, normal receptor expression, but defective reactivity to thrombopoietin. , 1997, Blood.

[34]  P. Krishnamurthy,et al.  Acute myeloid leukemia in TAR syndrome , 1997, Indian journal of pediatrics.

[35]  M. Okuma,et al.  Thrombopoietin, c‐Mpl ligand, induces tyrosine phosphorylation of Tyk2, JAK2, and STAT3, and enhances agonists‐induced aggregation in platelets in vitro , 1995, FEBS letters.

[36]  B. Camitta,et al.  Acute lymphoidic leukemia in a patient with thrombocytopenia/absent radii (Tar) syndrome. , 1993, The American journal of pediatric hematology/oncology.

[37]  B. Shank,et al.  Marrow transplantation for thrombocytopenia-absent radii syndrome. , 1992, The Journal of pediatrics.

[38]  P. D. de Alarcon,et al.  Thrombocytopenia and absent radii syndrome: defective megakaryocytopoiesis-thrombocytopoiesis. , 1991, The American journal of pediatric hematology/oncology.

[39]  A. Homans,et al.  Defective megakaryocytopoiesis in the syndrome of thrombocytopenia with absent radii , 1988, British journal of haematology.

[40]  J. Lipton,et al.  Thrombocytopenia with absent radii. A review of 100 cases. , 1988, The American journal of pediatric hematology/oncology.

[41]  E. Zackai,et al.  Thrombocytopenia with absent radius in a boy and his uncle. , 1987, American journal of medical genetics.

[42]  Y. Sultan,et al.  Abnormal platelet function, population, and survival-time in a boy with congenital absent radii and thrombocytopenia. , 1972, Lancet.

[43]  H. Holmsen,et al.  Platelet adenine nucleotide "storage pool deficiency" in thrombocytopenic absent radii syndrome. , 1972, JAMA.

[44]  V. McKusick,et al.  THROMBOCYTOPENIA WITH ABSENT RADIUS (TAR) , 1969, Medicine.